SMARCA2/4-Dependent Chromatin Remodelling Establishes Gene Regulatory Programs in Early Human Embryos and Blastoids

preprint OA: closed
Full text JSON View at publisher

Abstract

Gene regulatory networks establish cell identity during development by regulating transcription factor binding at cis-regulatory elements, many of which require chromatin remodelers for accessibility. Although these key principles of gene regulation in mammalian development have emerged, the contribution of chromatin remodellers to early human embryogenesis remains unclear. Here, we show that the SWI/SNF ATPases SMARCA2 and SMARCA4 are essential for establishing gene regulatory programs and cell identity in human pre-implantation development by facilitating enhancer accessibility. Using both human blastoids and human blastocysts, we find that loss of SMARCA2/4 disrupts blastoid epiblast identity, enhances trophectoderm initiation, and impairs inner cell mass formation and developmental progression. Integrative single-cell chromatin accessibility and transcriptome profiling in blastoids reveals that SMARCA2/4 safeguard naïve epiblast and trophectoderm programs by maintaining enhancer and transcription factor binding motif accessibility. These findings identify SWI/SNF chromatin remodellers as critical regulators of embryonic lineage specification during human pre-implantation development.
Full text 1,502 characters · extracted from oa-doi-fallback · click to expand
Abstract Gene regulatory networks establish cell identity during development by regulating transcription factor binding at cis-regulatory elements, many of which require chromatin remodelers for accessibility. Although these key principles of gene regulation in mammalian development have emerged, the contribution of chromatin remodellers to early human embryogenesis remains unclear. Here, we show that the SWI/SNF ATPases SMARCA2 and SMARCA4 are essential for establishing gene regulatory programs and cell identity in human pre-implantation development by facilitating enhancer accessibility. Using both human blastoids and human blastocysts, we find that loss of SMARCA2/4 disrupts blastoid epiblast identity, enhances trophectoderm initiation, and impairs inner cell mass formation and developmental progression. Integrative single-cell chromatin accessibility and transcriptome profiling in blastoids reveals that SMARCA2/4 safeguard naïve epiblast and trophectoderm programs by maintaining enhancer and transcription factor binding motif accessibility. These findings identify SWI/SNF chromatin remodellers as critical regulators of embryonic lineage specification during human pre-implantation development. Competing Interest Statement The KU Leuven University, Belgium, has filed a patent application PCT/EP2023/073949 describing the protocols for inducing EXMCs using naive human pluripotent stem cells. V.P. is a co-inventor of this patent. All other authors declare no competing interests.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00